1 / 16

Anemia and transfusion guidelines in adults

Anemia and transfusion guidelines in adults. Pablo M. Bedano M.D. Community Regional Cancer Care. Most common indications for red blood cell transfusion:. Treatment of symptomatic anemia Prophylaxis of life threatening anemia

braith
Download Presentation

Anemia and transfusion guidelines in adults

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anemia and transfusion guidelines in adults Pablo M. Bedano M.D. Community Regional Cancer Care

  2. Most common indications for red blood cell transfusion: • Treatment of symptomatic anemia • Prophylaxis of life threatening anemia • Restoration of oxygen-carrying capacity in the case of hemorrhage

  3. Role of blood transfusion: • Oxygen delivery (DO2)= cardiac output x arterial O2 content • At rest in healthy adults delivery exceeds consumption x4 • Delivery can be raised by increasing cardiac output • Ill adults with other medical comorbidities may have impaired compensatory mechanisms

  4. Effects of low Hgb in healthy adults: • 31 healthy adults had aliquots of blood (450-900 ml) removed to achieve Hgb 5 g/dL • Isovolemia was maintained • Statistically significant increases in heart rate and stroke volume (increased cardiac output) • Cognitive function impaired at Hgb 5-6 • No increase in plasma lactate concentration • 2 individuals developed reversible EKG changes consistent with ischemia Weiskopff et al JAMA. 1998 Jan 21;279(3):217-21.

  5. Impact of anemia on morbitity and mortality: • A retrospective cohort study of 1958 patients who declined transfusion for religious reasons showed 30 day mortality 1.3% Hgb >12 g/dL, 33% if Hb <6, greater odds of death if underlying CV disease • A subset analysis of 300 post-operative patients postoperative risk of death increased progressively when Hb < 7 g/dL • Retrospective review of 310,311 patients undergoing non-cardiac surgery revealed 10% increase cardiac events Hct 36-38.9, 52% Hct 18-20.9 Carson et al Lancet 1996; 348:1055 Carson et al Transfusion 2002; 42:812 Wu et al JAMA 2007; 297:2481

  6. Risks and complications of transfusions: • Infection • Allergic reactions • Volume overload • Iron overload • Cost

  7. Transfusion thresholds AABB: • Hgb < 6 g/dL– Transfusion recommended except in rare circumstances • Hgb 6 to 7 g/dL – Transfusion likely to be recommended • Hgb 7-8 g/dL – Consider transfusion in postoperative surgical patients • Hgb 8-10 g/dL – Transfusion generally not indicated, consider in special situations (symptomatic anemia, ongoing bleeding, acute coronary syndrome with ischemia • Hgb > 10 g/dL – Transfusion generally not indicated

  8. Cochrane review: • 19 randomized clinical trials identified including 6264 patients • All trials included used a transfusion threshold • Most trials used thresholds between 7-10 • 39% decrease in probability of receiving transfusion • Fewer units (1.19) transfused per patient • Trend towards lower 30 day mortality • Trend toward lower infection rate, no difference seen with pneumonia • No difference in functional recovery or length of stay Carson et al JAMA 2013; 309:83

  9. Risk of myocardial infarction: • No increased risk of MI found on meta-analysis • TRICC 838 ICU patients with Hgb <9 within 72 hs. admission, randomized to liberal (Hgb>10) vs. restrictive (hgb>7). Lower overall mortality in restrictive group, lower risk of MI (0.7 vs 2.9%) • FOCUS 2016 patients >50 with history or risk factors for CAD and Hgb < 10 g/dL after hip surgery randomized to liberal (Hgb>10) or restrictive (Hgb>8) transfusion threshold. No-statistically significant increase of MI (3.8 vs 2.3). No difference in survival Hebert et al NEJM 1999; 340:409-417 Carson et al NEJM 2011; 365(26):2453-62

  10. Acute coronary syndrome: • Most guidelines recommend transfusion when Hgb between 8-10 g/dL in the setting of active ischemia • Pilot trial 110 patients with ACS undergoing cardiac cath. with Hgb < 10 g/dL. Randomized to liberal (>10) vs restrictive (>8). Endpoint death, MI or revascularization <30 days. Trend to better outcome in liberal group (10.9% vs 25.5% P=0.54) Carson et al Am Heart J 2013; 165:964

  11. Congestive heart failure: • AABB guidelines recommend transfusion threshold of 8 g/dL in asymptomatic patient and 7-10 g/dL in symptomatic patient • Fluid overload is a concern

  12. Acute bleeding: • In case of massive bleeding transfusion should be guided by rate of bleeding and not Hgb • Hemodynamically stable patients restrictive strategy may be safe • Single center trial randomized 921 patients with acute upper GI bleed to restrictive (Hgb>7) vs liberal (Hgb >9) strategy, excluding massive bleeding, ACS or CVD. All patients underwent endoscopic treatment within 6 hs • Lower rate of transfusion (49 vs 89 percent) • Fewer deaths from bleeding (0.7 vs 3.1 percent) and from any cause (5 vs 9 percent)

  13. Transfusion and surgery: • Based on FOCUS trial a transfusion threshold of Hgb 8 g/dL seems to be safe • Hgb threshold of 8 g/dL seems safe in patients undergoing cardiac surgery with cardiopulmonary bypass • 428 patients randomized to threshold 8 vs 9, no differences in outcome • TRACS 502 patients undergoing cardiac surgery with CP bypass, no differences in outcome. Independent of transfusion strategy, overall mortality correlated with number of transfusions Bracey et al Transfusion 1999;39:1070 Hajjar et al JAMA 2010; 304:1559

  14. Cancer patients: • In patients undergoing active treatment maintain Hgb > 7-8 g/dL • No randomize studies to guide palliative benefit of blood transfusions in terminal patients

  15. Conclusions: • Multiple clinical trials validate a restrictive transfusion strategy for most adults, with threshold Hgb 7-8 g/dL • In medically stable ICU patients Hgb threshold of 7 g/dL safe based on TRICC trial • Symptomatic patients with Hgb <10 g/dL should be transfused as clinically indicated • In patients with acute coronary syndrome, Hgb should be kept > 8 g/dL and > 10 g/dL in ongoing ischemia • Patients with massive bleeding cannot be managed based on Hgb thresholds • Transfusion on 1 unit of blood at a time is reasonable in the hemodynamicallystable patient

More Related